Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-01

Clinical Trial Update: Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting long-term safety data for tacrolimus ointment in young children with atopic dermatitis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tacrolimus ointment (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED